Cumberland Pharmaceuticals(CPIX) - 2023 Q4 - Annual Results

Cumberland Pharmaceuticals Reports Annual 2023 Financial Results 2023 highlights include expanded FDA approval and new study publications NASHVILLE, TENNESSEE (Tuesday, March 5, 2024) – Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that its product portfolio of FDA-approved brands delivered combined revenues of $40 million in 2023 and provided $6 million in cash generated from operations. Cumberland ended the year with $82 million in total assets – inclu ...